GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anatara Lifesciences ANR.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Anatara Lifesciences — daily ASX:ANR

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Anatara Lifesciences on TradingView ↗
Market value
A$2.5m
Last close × shares

About Anatara Lifesciences

Its shares trade on ASX under the ticker ANR.AX. It has been listed since 16 October 2014. In the fiscal year to 30 June 2025, it reported revenue of A$969,456 and a net loss of A$2.0m. At that date it held total assets of A$1.1m and shareholders' equity of A$535,968.

Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company is headquartered in Melbourne, Victoria. The company went IPO on 2014-10-16. The firm is engaged in developing and commercializing evidence-based products for gastrointestinal health. The company develops products for human and animal health. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.

Figures and description from our data supplier, not checked against the company's own report.

More about Anatara Lifesciences →

Latest on Anatara Lifesciences

Our reporting

We have not reported on Anatara Lifesciences yet.

Next results

24 Feb 2027

Due on 24 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Anatara Lifesciences's ticker?

Anatara Lifesciences trades as ANR.AX on ASX, under ISIN AU000000ANR0.

What was Anatara Lifesciences's last closing price?

0.01 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Anatara Lifesciences next report results?

Results are expected on 24 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.